Literature DB >> 18663653

Managing hypertension in the elderly in light of the changes during aging.

Talma Rosenthal1, Naomi Nussinovitch.   

Abstract

The natural rise in systolic blood pressure with age is often complicated by other co-morbidities. Pharmacokinetics and pharmacodynamics of antihypertensive drugs are altered during aging, resulting in decrease in absorption and function of the kidney and liver, as well as interactions and adverse reactions of antihypertensives with the often large number of medications taken by the elderly. The problem of compliance in the elderly that may be disrupted by depression, loss of memory, vascular dementia and other conditions that compromise cognition is also of concern. Despite the many issues facing healthcare providers in managing hypertension in the elderly, the benefits are extensively documented and warrant overcoming therapeutic inertia, especially in view of current access to well documented therapeutic options.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18663653     DOI: 10.1080/08037050802305578

Source DB:  PubMed          Journal:  Blood Press        ISSN: 0803-7051            Impact factor:   2.835


  4 in total

1.  Antihypertensive Adherence Trajectories Among Older Adults in the First Year After Initiation of Therapy.

Authors:  Jennifer L Hargrove; Virginia Pate; Carri H Casteel; Yvonne M Golightly; Laura R Loehr; Stephen W Marshall; Til Stürmer
Journal:  Am J Hypertens       Date:  2017-10-01       Impact factor: 2.689

2.  Adverse effects using combined rate-slowing antihypertensive agents.

Authors:  Joel Handler
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-06-20       Impact factor: 3.738

Review 3.  Factors associated with clinical inertia: an integrative review.

Authors:  Isabelle Aujoulat; Patricia Jacquemin; Ernst Rietzschel; André Scheen; Patrick Tréfois; Johan Wens; Elisabeth Darras; Michel P Hermans
Journal:  Adv Med Educ Pract       Date:  2014-05-08

4.  Use of Drugs With Risk of Heart Rate-Related Problems is Common in Norwegian Dementia Patients Treated With Acetylcholinesterase Inhibitors: A Prevalence Study Based on the Norwegian Prescription Database.

Authors:  Anne Sverdrup Efjestad; Hege Ihle-Hansen; Vidar Hjellvik; Knut Engedal; Hege Salvesen Blix
Journal:  Front Pharmacol       Date:  2022-02-22       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.